Skip to main content
Menu
  • Meet Idylla
    • Idylla Platform
    • Oncology Tests
    • Publications
  • Oncology
    • Oncology Tests
    • Oncologist
    • Pathologist
    • On-Demand Webinars
  • Oncology Research
    • Research Assays
    • IIS Information
    • On-Demand Webinars
  • Partnering
    • Content Partnering
    • Pharma Partnering
    • Partnering Contact
    • Global Commercialization
  • Press & Events
    • Press Releases
    • Events
  • About Us
    • Team
    • Our Distributors
    • Careers
    • Download Center
    • Contact
  • IFU
  • Secure area
  • Global
  • United States
Open/Close
  • Search
  • Contact us
  • +32 15 632 600
  • Subscribe to news
  • Global
  • United States

2025 product launches

  1. Home
  2. 2025 product launches
Menu
  • Meet Idylla
    • Idylla Platform
    • Oncology Tests
    • Publications
  • Oncology
    • Oncology Tests
    • Oncologist
    • Pathologist
    • On-Demand Webinars
  • Oncology Research
    • Research Assays
    • IIS Information
    • On-Demand Webinars
  • Partnering
    • Content Partnering
    • Pharma Partnering
    • Partnering Contact
    • Global Commercialization
  • Press & Events
    • Press Releases
    • Events
  • About Us
    • Team
    • Our Distributors
    • Careers
    • Download Center
    • Contact
POLE-POLD1 RUO Cartridge

Idylla POLE-POLD1 Mutation Assay

Fully automated detection of 17 POLE mutations and 1 POLD1 mutation, directly from 1 FFPE tissue section.

Read more
Idylla EGFR Mutation Test

Idylla EGFR Mutation Test

Fully automated detection of 44 mutations, directly from 2 FFPE tissue sections from patients with NSCLC.

Read more
msi-cdx_pma_website_cartridge_1920_x_1080_px.png

Idylla CDx MSI Test

COMING SOON

Fully automated detection of MSI to identify MSI-H CRC patients who may benefit from treatment with nivolumab alone, or in combination with ipilimumab. 

Read more

*Idylla™ POLE-POLD1 Mutation Assay is for Research Use Only (RUO), not for use in diagnostic procedures. 
**Idylla™ EGFR Mutation Test (A0270/6) is CE-marked in Europe in compliance with the EU IVD Regulation 2017/746 (IVDR).
***Idylla™ CDx MSI Test (A0220/6) is approved in the US under P250005. 

  • Meet Idylla
  • Oncology
  • Oncology Research
  • Partnering
  • Press & Events
  • About Us

Biocartis NV

Generaal De Wittelaan 11B

2800 Mechelen, Belgium

Phone: +32 15 632 600

[email protected]

 

Biocartis US

  • Subscribe to news
  • Contact us
  • Request demo
  • Download center
  • LinkedIn
  • Facebook
  • YouTube
  • Twitter
  • Cookie policy
  • Privacy policy
  • Terms of use
© 2026 Biocartis Created by O2 Agency